IL17RB expression is associated with malignant cancer behaviors and poor prognosis in oral cancer.
Shyng-Shiou F YuanChang-Wei SuLeong-Perng ChanHieu D H NguyenYuk-Kwan ChenJe-Kang DuKuang-Hung ChengYen-Yun WangPublished in: Oral diseases (2023)
Clinical and in vitro studies suggest that IL17RB might serve as an independent risk factor and a therapeutic target for oral cancer.